Savient Pharmaceuticals, Inc. Bankruptcy New Filing Alert: Required Bankruptcy Report Regarding Schedules Of Assets And Liabilities, Statement Of Financial Affairs, Monthly Operating Report Or Other Periodic Report

On July 20, 2015, a required bankruptcy report regarding schedules of assets and liabilities, statement of financial affairs, monthly operating report or other periodic report was filed in the bankruptcy case of Savient Pharmaceuticals, Inc. and its affiliates.

The filing was assigned docket number 864 and is described on the court’s official docket as follows:

Post-Confirmation Report , Reporting Period April 1, 2015 Through June 30, 2015. Filed by SPI Liquidating Trust. (Attachments: # (1) Affidavit of Service) (Keane, Peter J.)

Savient Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 14, 2013. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 13-12680. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Skadden, Arps, Slate, Meagher & Flom LLP is acting as lead bankruptcy counsel to Savient Pharmaceuticals, Inc. in the bankruptcy case.


Leave a Reply